Canada Pension Plan Investment Board
GBT

Canada Pension Plan Investment Board’s Global Blood Therapeutics, Inc. GBT Stock Holding History

Canada Pension Plan Investment Board’s Portfolio GBT Stock Details GBT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-88,100
Closed -$6M – 1306
2022
Q3 		$6M Buy
88,100
+4,899
+6% +$270K 0.01% 499
2022
Q2 		$2.66M Buy
83,201
+81,600
+5,097% +$2.39M ﹤0.01% 644
2022
Q1 		$55K Sell
1,601
-2,688
-63% -$80.4K ﹤0.01% 1224
2021
Q4 		$126K Sell
4,289
-4,065
-49% -$126K ﹤0.01% 1314
2021
Q3 		$213K Buy
+8,354
New +$246K ﹤0.01% 1207
2020
Q4 		– Sell
-755
Closed -$42K – 1491
2020
Q3 		$42K Sell
755
-1,507
-67% -$95.8K ﹤0.01% 1019
2020
Q2 		$143K Buy
2,262
+2,252
+22,520% +$154K ﹤0.01% 1235
2020
Q1 		$1K Buy
+10
New +$670 ﹤0.01% 1275
2019
Q4 		– Sell
-6,792
Closed -$330K – 1497
2019
Q3 		$330K Buy
+6,792
New +$354K ﹤0.01% 1077

Other funds holding GBT

BTI
Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $20.6B AUM 34.61% 1-Year Est. Return

Canada Pension Plan Investment Board's GBT Position: Q4 2022 in Review

Canada Pension Plan Investment Board sold out of Global Blood Therapeutics, Inc. (GBT) in Q4 2022, closing a stake of 88,100 shares — an estimated $6M sold.

Canada Pension Plan Investment Board first reported a position in GBT in Q3 2019 and held it in 9 quarters. The position peaked at $6M in Q3 2022. 2 funds tracked by Wall St. Rank hold GBT as of Q4 2022.

  • Canada Pension Plan Investment Board reported no remaining Global Blood Therapeutics, Inc. position as of Q4 2022 after selling out during the quarter.
  • Canada Pension Plan Investment Board sold 88,100 Global Blood Therapeutics, Inc. shares in Q4 2022, an estimated $6M.
  • Canada Pension Plan Investment Board first reported a position in Global Blood Therapeutics, Inc. in Q3 2019 and held it in 9 quarters.
  • Canada Pension Plan Investment Board's Global Blood Therapeutics, Inc. position peaked at $6M in Q3 2022.
  • 2 funds tracked by Wall St. Rank held Global Blood Therapeutics, Inc. as of Q4 2022.

Based on Canada Pension Plan Investment Board's 13F filing for Q4 2022, filed 14 Feb 2023.